Peregrine Pharma (PPHM) – Hot Corp. News
-
Peregrine Pharma (PPHM) Appoints Roger J. Lias PhD as President and CEO
-
Peregrine Pharma (PPHM) Reports First Patient Dosed in Phase II Clinical Trial Evaluating Bavituximab Treatment Combination in Patients with Newly Diagnosed Glioblastoma
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to PPHM Stock Lookup